PCVX — VAXCYTE INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 346 SEC-registered investment managers reported holding PCVX (VAXCYTE INC) in their latest 13F filings, with a combined reported value of $10.41B across 182.07M shares. That is +6.2% by share count (+9.15M shares) versus the previous quarter, while reported value moved +5.0%. Ownership is concentrated: the five largest holders account for 41.6% of reported value and the top ten for 59.1%.
Compared with the prior quarter, 48 opened new positions, 135 added to existing stakes, 103 trimmed, 55 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of VAXCYTE INC (PCVX) include Fidelity Management & Research (FMR), Jupiter Topco LLC, Janus Henderson Group, ranked by reported 13F value among the 648 institutional holders on this page.
PCVX is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Legendary Investors Holding PCVX
The superinvestors we track who report PCVX in their latest 13F filing — each shown at that manager’s own most recent quarter.
| Investor | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
|
|
Q2 2026 | 1.61M | $93.78M | 0.85% | Add |
|
|
Q1 2026 | 800.00K | $46.49M | 0.91% | New |
Which stocks do these investors own together? → · Embed this widget →
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 256 | 82.31M | $4.69B | +6.1% |
| Q2 2026 | 346 | 182.07M | $10.41B | +6.2% |
| Q1 2026 | 351 | 175.80M | $10.15B | +7.4% |
| Q4 2025 | 303 | 160.73M | $7.36B | +1.7% |
| Q3 2025 | 291 | 156.42M | $5.57B | -4.4% |
| Q2 2025 | 300 | 163.13M | $5.18B | +1.8% |
| Q1 2025 | 322 | 163.91M | $6.41B | +4.9% |
| Q4 2024 | 328 | 155.68M | $12.38B | +5.0% |
Over the 8 quarters shown, institutional share counts decreased 47% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q1 2026 (+7.4%).
Top Institutional Holders (Q3 2026) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 22.48M | $1.28B | 0.06% | Add | |
| 12.18M | $693.04M | 0.01% | Add | |
| 6.57M | $373.94M | 0.01% | Add | |
| 6.57M | $373.82M | 0.02% | Hold | |
| 5.23M | $297.68M | 0.01% | Add | |
| 3.49M | $198.89M | 0.01% | Add | |
| 3.28M | $186.60M | 0.61% | Add | |
| 1.43M | $81.11M | 33.06% | Hold | |
| 1.42M | $80.92M | 0.01% | Add | |
| 1.38M | $78.53M | 1.10% | Hold | |
| 1.10M | $63.05M | 0.01% | Reduce | |
| 1.06M | $60.50M | 0.00% | Add | |
| 963.50K | $54.82M | 0.01% | Add | |
| 854.20K | $48.60M | 0.08% | Add | |
| 835.60K | $47.55M | 0.01% | Hold | |
| 824.00K | $46.89M | 0.04% | Add | |
| 788.03K | $44.84M | 0.02% | Add | |
| 602.88K | $34.30M | 0.05% | Hold | |
| 500.31K | $32.86M | 0.01% | Add | |
| 563.32K | $32.05M | 0.01% | Reduce | |
| 545.43K | $31.04M | 0.03% | Reduce | |
| 502.88K | $28.61M | 0.01% | Hold | |
| 460.31K | $26.19M | 0.01% | Add | |
| 447.26K | $25.54M | 0.12% | Add | |
| 392.78K | $22.35M | 0.01% | Add |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
Q1 2026 — 25 funds
Q4 2025 — 25 funds
Q3 2025 — 25 funds
Q2 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 14.69M | $477.66M | 0.23% | Add | |
| 12.15M | $395.03M | 0.02% | Reduce | |
| 12.00M | $390.03M | 0.01% | Hold | |
| 11.97M | $389.01M | 6.55% | Reduce | |
| 10.64M | $345.98M | 0.01% | Add | |
| 6.00M | $195.10M | 0.12% | Add | |
| 4.95M | $161.08M | 0.03% | Reduce | |
| 4.95M | $161.08M | 0.03% | Reduce | |
| 4.94M | $160.67M | 0.01% | Add | |
| 4.77M | $155.13M | 0.03% | Reduce | |
| 4.77M | $155.13M | 0.03% | Reduce | |
| 3.37M | $109.65M | 4.68% | Add | |
| 3.17M | $103.07M | 0.01% | Reduce | |
| 3.09M | $100.41M | 0.23% | Add | |
| 3.09M | $100.41M | 0.08% | Add | |
| 3.07M | $99.86M | 10.75% | Reduce | |
| 3.07M | $99.77M | 0.42% | Add | |
| 3.01M | $97.90M | 0.01% | Add | |
| 2.15M | $69.90M | 2.25% | Add | |
| 1.42M | $46.09M | 0.01% | Add | |
| 1.42M | $46.09M | 0.01% | Add | |
| 1.40M | $45.49M | 0.03% | Add | |
| 1.38M | $44.89M | 0.03% | Add | |
| 1.31M | $42.61M | 0.65% | Add | |
| 1.31M | $42.61M | 0.64% | Add |
New Positions (Q2 2026)
- Jupiter Topco LLC 17.97M sh · $1.04B
- GEODE CAPITAL MANAGEMENT, LLC 3.46M sh · $201.13M
- Sixth Street Partners Management Company, L.P. 1.46M sh · $85.15M
- First Turn Management, LLC 443.84K sh · $25.80M
- Jump Financial, LLC 135.00K sh · $7.85M
- Nicholas Investment Partners, LP 131.13K sh · $7.62M
- Edgestream Partners, L.P. 131.12K sh · $7.62M
- HOMESTEAD ADVISERS CORP 34.40K sh · $2.00M
- Engineers Gate Manager LP 32.78K sh · $1.91M
- Legato Capital Management LLC 21.64K sh · $1.26M
- NEW YORK LIFE INVESTMENT MANAGEMENT LLC 17.56K sh · $1.02M
- SIG BROKERAGE, LP 15.60K sh · $906.83K
Fully Exited (vs previous quarter)
- Janus Henderson Group sold 16.58M sh · $960.23M
- STATE STREET CORP sold 4.44M sh · $258.04M
- Farallon Capital Management sold 1.26M sh · $73.28M
- FARALLON CAPITAL MANAGEMENT, L.L.C. sold 1.26M sh · $73.28M
- BAUPOST GROUP LLC/MA sold 800.00K sh · $46.49M
- Trails Edge Capital Partners, LP sold 662.47K sh · $38.50M
- Jones Hill Capital LP sold 644.83K sh · $37.47M
- Point72 Asset Management sold 620.40K sh · $36.05M
- Balyasny Asset Management sold 514.58K sh · $29.90M
- Soleus Capital Management, L.P. sold 385.47K sh · $22.40M
- Logos Global Management LP sold 300.00K sh · $17.43M
- Freestone Grove Partners LP sold 224.73K sh · $13.06M
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fidelity Management & Research (FMR) | 22.48M | 20.85M | 16.49M | 13.83M | 12.51M | 12.15M | 12.51M | 13.09M | 15.80M | 16.17M | 16.26M | 14.21M | 14.08M | 14.06M | 11.81M | 10.17M | 8.90M | 8.51M | 8.38M | 7.87M |
| BlackRock Inc | 12.18M | 12.07M | 10.97M | 10.25M | 9.96M | 10.64M | 10.58M | 11.11M | 10.67M | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 6.57M | 6.35M | 6.27M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 6.57M | 6.59M | 6.28M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| STATE STREET CORP | 5.23M | — | 4.44M | 4.98M | 4.79M | 4.94M | 4.41M | 4.54M | 3.41M | 3.37M | 3.34M | 3.39M | 3.15M | — | — | — | — | — | — | — |
| Geode Capital Management | 3.49M | 3.46M | 3.20M | 2.87M | 2.88M | 3.01M | 2.87M | 2.80M | 2.70M | 2.44M | 2.29M | 1.97M | 1.88M | 1.69M | 1.33M | 1.25M | 894.79K | 779.70K | 721.96K | 655.72K |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 3.28M | 2.47M | 3.65M | 3.54M | 3.73M | 3.07M | 2.16M | 2.57M | 1.74M | 1.93M | 1.59M | 1.46M | 1.00M | — | — | — | — | — | — | — |
| Pivotal bioVenture Partners Investment Advisor LLC | 1.43M | 1.43M | 1.37M | 1.37M | 1.37M | 1.31M | 710.73K | 703.83K | 639.54K | 793.04K | 793.04K | 793.04K | 793.04K | — | — | — | — | — | — | — |
| DIMENSIONAL FUND ADVISORS LP | 1.42M | 1.19M | 375.77K | 191.79K | 28.37K | 109.88K | 227.43K | 293.71K | 136.43K | 35.64K | 47.51K | 34.44K | 40.72K | — | — | — | — | — | — | — |
| EVENTIDE ASSET MANAGEMENT, LLC | 1.38M | 1.38M | 1.37M | 917.12K | 379.33K | 848.14K | 470.23K | 383.45K | 383.45K | 739.15K | 657.21K | 607.21K | 393.00K | — | — | — | — | — | — | — |
| JPMorgan Chase & Co | 1.10M | 1.23M | 1.01M | 1.09M | 1.57M | 1.20M | 1.90M | 30.00K | 30.00K | 1.21M | 2.80K | 405.33K | 637.72K | 356.41K | 5.60K | 252.93K | 180.13K | 44.17K | 26.79K | 20.40K |
| Morgan Stanley | 1.06M | 797.72K | 735.91K | 835.39K | 784.48K | 841.92K | 606.95K | 693.33K | 694.87K | 409.69K | 490.45K | 537.37K | 409.55K | 425.09K | 170.62K | 168.12K | 42.53K | 137.67K | 88.93K | 57.84K |
| VANGUARD FIDUCIARY TRUST CO | 963.50K | 930.64K | 842.27K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| BNP PARIBAS FINANCIAL MARKETS | 854.20K | 465.48K | 224.52K | 50.76K | 257.67K | 139.12K | 50.43K | 91.27K | — | — | — | — | — | — | — | — | — | — | — | — |
| Capital Research Global Investors | 835.60K | 836.76K | 912.69K | 842.98K | 842.98K | 4.77M | 6.11M | 6.21M | 4.90M | 4.13M | 4.14M | 3.44M | 3.36M | — | — | — | — | — | — | — |
| Clearbridge Investments, LLC | 824.00K | 752.00K | 128.38K | — | — | 646.05K | 1.22M | 1.10M | 1.16M | 186.14K | — | — | — | — | — | — | — | — | — | — |
| AMERICAN CENTURY COMPANIES INC | 788.03K | 782.18K | 355.85K | 357.30K | 344.03K | 351.05K | 587.05K | 605.27K | 529.00K | 527.59K | 461.72K | 407.23K | 371.74K | — | — | — | — | — | — | — |
| FEDERATED HERMES, INC. | 602.88K | 601.16K | 566.83K | 523.49K | 18.16K | 261 | — | 326.06K | 501.05K | 425.64K | 425.75K | 394.19K | 395.81K | — | — | — | — | — | — | — |
| Franklin Resources | 500.31K | 476.00K | 473.36K | 336.14K | 336.11K | 939.27K | 3.09M | 2.87M | 2.79M | 2.46M | 2.15M | 1.08M | 955.93K | 752.40K | 716.24K | 5.20K | — | — | — | — |
| UBS Group AG | 563.32K | 776.51K | 1.34M | 1.09M | 847.57K | 1.38M | 1.08M | 736.56K | 111.57K | 95.68K | 176.08K | 166.03K | 74.31K | 45.82K | 344 | 122.72K | 75 | 23.57K | 60.39K | 45.23K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold PCVX?
As of 2026-Q2, 346 institutional funds reported holding PCVX (VAXCYTE INC) in SEC 13F filings, with a combined reported value of $10.41B.
How many shares of PCVX do institutions own?
13F filers reported 182.07M shares of PCVX, worth $10.41B in aggregate at the end of 2026-Q2.
Is institutional ownership of PCVX rising or falling?
Share counts moved +6.2% versus the prior quarter — accumulation.
Who are the top institutional holders of PCVX?
The largest 13F holders are Fidelity Management & Research (FMR), Jupiter Topco LLC, Janus Henderson Group, T. Rowe Price Investment Management, Inc., BlackRock Inc; the top 25 are ranked at the top of this page.
Who are the major shareholders of VAXCYTE INC?
The major shareholders of VAXCYTE INC (PCVX) by reported 13F value are Fidelity Management & Research (FMR), Jupiter Topco LLC, Janus Henderson Group, T. Rowe Price Investment Management, Inc., BlackRock Inc, among 648 institutional holders.
Which legendary investors own PCVX?
2 of the legendary investors tracked on HoldingsHub report PCVX (VAXCYTE INC) in their latest 13F filings, led by Lee Ainslie, Seth Klarman. Each is shown at that manager's own most recent quarter.
Do superinvestors agree on PCVX?
2 tracked superinvestors hold PCVX simultaneously — see the consensus page for the stocks they own together.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.